US15687V1098 - Common Stock
CERTARA INC
NASDAQ:CERT (4/23/2024, 7:00:00 PM)
After market: 17.67 +0.94 (+5.62%)16.73
+0.57 (+3.53%)
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Princeton, New Jersey and currently employs 1,150 full-time employees. The company went IPO on 2020-12-11. The firm is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. The firm builds its biosimulation technology on the first principles of biology, chemistry, and pharmacology with mathematical algorithms that model how medicines and diseases behave in the body. The company offers an integrated, end-to-end platform for its clients, including various biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries. The company also provides an artificial intelligence-powered platform for organizations to integrate and analyze content across their entire enterprise data landscape. The company has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland and the United Kingdom.
CERTARA INC
100 Overlook Center, Suite 101
Princeton NEW JERSEY 08540
P: 16097167900
CEO: William F. Feehery
Employees: 1150
Website: https://www.certara.com/
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release...
Provides Full Year 2024 Financial Guidance
Provides Full Year 2024 Financial Guidance...
Here you can normally see the latest stock twits on CERT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: